
Academic Journal
Q3Critical Reviews in Immunology
About Critical Reviews in Immunology
Critical Reviews in Immunology is a scholarly journal published by Begell House Inc.. SCImago 2025 lists it in Q3, with an SJR of 0.558 and H-index of 91.
Coverage: 1980-2026. Research categories: Immunology (Q3); Immunology and Allergy (Q3).
Source-backed journal facts
Topics in published research
Immune Cell Function and Interaction; T-cell and B-cell Immunology; Immunotherapy and Immune Responses; Immune Response and Inflammation; CAR-T cell therapy research; Cancer Immunotherapy and Biomarkers.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Ciprofol combined with CA1 overexpression suppresses colorectal cancer tumorigenesis via p53 signaling pathway
Zhuo Chen, Quanfu Li, Tian Xia, Guangjun Hu et al.
2026 · DOI: 10.1615/critrevimmunol.2026065692SIHA2 Promotes Hepatocellular Carcinoma Progression by Mediating Ubiquitination and Degradation of DDIT4
Xin Wen, Ming Ji, Kuan Cao, Zhiyi Liu et al.
2026 · DOI: 10.1615/critrevimmunol.2025060826Single-Cell Sequencing Combined with RNA Sequencing Reveals the Role of Natural Killer Cells in Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma
Jiemin Lin, Meichun Lin, Lianxing Lin, Qiaojun Chen et al.
2026 · DOI: 10.1615/critrevimmunol.2025061164Regulatory B Cells: Beyond Antibody Production in Immunity and Cancer
Esmaeil Mortaz, Samaneh Abdolmohammadi-Vahid, Neda Dalil, Ian M. Adcock et al.
2026 · DOI: 10.1615/critrevimmunol.2026061778Single-Cell Transcriptomic Analysis Reveals ISG15 as a Key Regulator of Macrophage-Mediated Inflammation Driving Primary Sjögren's Syndrome Progression
Yajing Chao, Jian Dong, Kunting Chen, Yalu Fu et al.
2026 · DOI: 10.1615/critrevimmunol.2025060877PSMC2 Promotes Gallbladder Carcinoma Progression by Regulating the AKT/Cyclin D1/CDK6 Signaling Axis
Yiming Feng, Qin Yang, Lei Zhao, Jing Wang et al.
2026 · DOI: 10.1615/critrevimmunol.2026063698NK Cells In Endocrine Autoimmune Disorders: Current Knowledge and Implications for Therapeutic Strategies
Dorsa Iraji, Thea Sjøgren, Bergithe E. Oftedal
2026 · DOI: 10.1615/critrevimmunol.2026062734Construction of an Immunogenic Cell Death-Related Long Non-Coding RNA Signature for Predicting Prognosis in Osteosarcoma
Huihuang Luo
2026 · DOI: 10.1615/critrevimmunol.2025061145Combined Ursolic Acid and Rosuvastatin Treatment Mitigates Inflammation and Oxidative Stress in Diabetic Nephropathy Model Cells
Yijing Zhou, Chengli Lou, Xiangjing Wang, Pingxin Hu et al.
2026 · DOI: 10.1615/critrevimmunol.2026061077Oxymatrine Attenuates Lung Adenocarcinoma Tumorigenesis via METTL3-Mediated the m6A Modification of KAT2A
Zhuxia Nie
2026 · DOI: 10.1615/critrevimmunol.2026065687Engineered Dendritic Cells Imprint Dual Gut-Homing Specificity on Human Tregs for Pan-Intestinal Immunotolerance
Nisar Ali Shaikh, Xiao-Bing Zhang, David J. Baylink, Xiaolei Tang et al.
2026 · DOI: 10.1615/critrevimmunol.2026062974Circular RNA circ_0000064 Promotes Epithelial-Mesenchymal Transition of Lung Adenocarcinoma by Sponging miR-532-3p to Upregulate FOXM1 Expression
Liangliang Zhan, Mingyan Yu, Huanfeng Zhu, Li Ma et al.
2026 · DOI: 10.1615/critrevimmunol.2026065366Natural Killer Cells Significantly Target and Eliminate Chronic Myelogenous Leukemia via Direct Cytotoxicity or Antibody-Dependent Cellular Cytotoxicity
Kawaljit Kaur, Anahid Jewett
2026 · DOI: 10.1615/critrevimmunol.2025060370SLC2A1-Dependent Ketone Metabolism Regulates Tumor Progression and Immunotherapy Efficacy in Lung Adenocarcinoma
Xing Feng, Li Gao, Yonggang Xue, Yanbing Zhang et al.
2026 · DOI: 10.1615/critrevimmunol.2026062879Targeting Substance P–NK1R Signaling: Emerging Immunological Mechanisms and Therapeutic Promise of Substance P Inhibitors
Vijay Nimbarte
2026 · DOI: 10.1615/critrevimmunol.2026063398Knockdown of IGF2BP2 Inhibits THBS1 in Regulating the Progression of Oral Squamous Cell Carcinoma: An Integrative Analysis
Ying He, Wei Wang
2026 · DOI: 10.1615/critrevimmunol.2026061135Inhibition of METTL3-mediated STAT3 m6A modification enhances the sensitivity of head and neck squamous cell carcinoma to FGFR inhibitor AZD4547
Yao Hu, Fang Xiang, Yuan Jin, Dan Yu et al.
2026 · DOI: 10.1615/critrevimmunol.2026065812Toward a Unified Multidimensional HIV Cure: Integrating Virologic, Clinical, and Immunologic Perspectives
Seyi Samson Enitan, Chukwudi Amaechi Ofodile, Richard Yomi Akele, Ayodeji Olusola Olayanju et al.
2026 · DOI: 10.1615/critrevimmunol.2026064384Reviews
Community Reviews
Version History
October 4, 2026 at 9:15 pm
October 2, 2026